Arrowhead Pharmaceuticals Inc (ARWR) Insider Trading
- $301,336.35
- $143,830,412.54
- Dec. 18, 2024
- Christopher Richard Anzalone
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 18, 2024 | CEO | 26,712 | $21.24 | Sell | $567,362.88 | |
Dec. 16, 2024 | Director | 3,748 | $21.90 | Sell | $82,081.20 | |
July 2, 2024 | Insider | 9,394 | $25.28 | Sell | $237,480.32 | |
May 2, 2024 | Director | 1,799 | $23.31 | Sell | $41,934.69 | |
March 20, 2024 | Director | 1,000 | $27.50 | Buy | $27,500.00 | |
March 18, 2024 | Director | 1,000 | $27.49 | Buy | $27,490.00 | |
March 6, 2024 | CFO | 40,000 | $35.19 | Sell | $1,407,600.00 | |
Jan. 31, 2024 | CEO | 57,499 | $32.35 | Sell | $1,860,092.65 | |
Jan. 12, 2024 | Insider | 7,940 | $36.89 | Sell | $292,906.60 | |
Jan. 11, 2024 | Director | 2,911 | $38.06 | Sell | $110,792.66 | |
Jan. 5, 2024 | Insider | 32,143 | $35.18 | Sell | $1,130,790.74 | |
Jan. 5, 2024 | CFO | 16,104 | $35.27 | Sell | $567,988.08 | |
Jan. 5, 2024 | COO | 22,841 | $35.27 | Sell | $805,602.07 | |
Jan. 3, 2024 | Insider | 6,300 | $32.19 | Sell | $202,797.00 | |
Jan. 3, 2024 | COO | 8,749 | $32.28 | Sell | $282,417.72 | |
Jan. 2, 2024 | CEO | 9,952 | $31.01 | Sell | $308,611.52 | |
Dec. 20, 2023 | CEO | 12,000 | $28.54 | Sell | $342,480.00 | |
Nov. 20, 2023 | Insider | 19,700 | $28.80 | Sell | $567,360.00 | |
Oct. 25, 2023 | CEO | 24,338 | $24.21 | Sell | $589,222.98 | |
Sept. 28, 2023 | Director | 1,550 | $26.33 | Sell | $40,811.50 | |
Sept. 18, 2023 | CEO | 57,755 | $28.12 | Sell | $1,624,070.60 | |
July 3, 2023 | Insider | 8,925 | $35.31 | Sell | $315,141.75 | |
June 30, 2023 | Insider | 3,000 | $35.53 | Sell | $106,590.00 | |
June 27, 2023 | CFO | 15,000 | $36.20 | Sell | $543,000.00 | |
May 5, 2023 | Director | 6,500 | $40.90 | Sell | $265,850.00 | |
May 3, 2023 | CEO | 54,928 | $39.14 | Sell | $2,149,881.92 | |
March 3, 2023 | Director | 11,350 | $32.65 | Sell | $370,577.50 | |
Feb. 27, 2023 | Director | 875 | $32.62 | Sell | $28,542.50 | |
Jan. 9, 2023 | Director | 3,200 | $30.00 | Sell | $96,000.00 | |
Jan. 5, 2023 | COO | 15,000 | $37.39 | Sell | $560,850.00 | |
Jan. 5, 2023 | Insider | 13,803 | $37.40 | Sell | $516,232.20 | |
Jan. 3, 2023 | Insider | 10,338 | $38.38 | Sell | $396,772.44 | |
Jan. 3, 2023 | COO | 17,500 | $38.33 | Sell | $670,775.00 | |
Dec. 29, 2022 | CFO | 30,625 | $40.00 | Sell | $1,225,000.00 | |
Nov. 21, 2022 | Insider | 19,500 | $29.99 | Sell | $584,805.00 | |
Feb. 11, 2022 | CEO | 146,388 | $51.91 | Sell | $7,599,001.08 | |
Jan. 5, 2022 | General Counsel | 32,500 | $61.72 | Sell | $2,005,900.00 | |
Jan. 5, 2022 | CFO | 40,000 | $61.70 | Sell | $2,468,000.00 | |
Jan. 4, 2022 | SVP | 19,375 | $65.49 | Sell | $1,268,868.75 | |
Jan. 3, 2022 | Director | 4,500 | $64.72 | Sell | $291,240.00 | |
Dec. 28, 2021 | Director | 655 | $66.37 | Buy | $43,472.35 | |
Dec. 15, 2021 | CEO | 60,000 | $67.56 | Sell | $4,053,600.00 | |
Nov. 19, 2021 | Insider | 19,500 | $69.31 | Sell | $1,351,545.00 | |
Oct. 22, 2021 | CEO | 50,000 | $65.63 | Sell | $3,281,500.00 | |
Oct. 20, 2021 | CEO | 15,000 | $66.23 | Sell | $993,450.00 | |
Sept. 13, 2021 | Director | 5,000 | $63.76 | Sell | $318,800.00 | |
June 24, 2021 | Director | 5,000 | $89.85 | Sell | $449,250.00 | |
June 22, 2021 | Insider | 3,625 | $89.22 | Sell | $323,422.50 | |
June 22, 2021 | Director | 4,500 | $89.21 | Sell | $401,445.00 | |
Feb. 8, 2021 | General Counsel | 90,000 | $88.46 | Sell | $7,961,400.00 |
Insiders are both buying and selling Arrowhead Pharmaceuticals Inc stock.
The insider traders at Arrowhead Pharmaceuticals Inc are: Christopher Richard Anzalone, Kenneth Allen Myszkowski, Bruce D Given, Patrick O'brien, Douglas B Given, James C Hamilton, Douglas B. Given, Backer Marianne De, William D Waddill, Martin Javier San, Mauro Ferrari, Michael S Perry, Adeoye Y Olukotun, Charles Mckenney, David L Lewis, Hongbo Lu, James Hassard, Tracie Oliver, Victoria Vakiener, Zhen Li, Peter Brian Leone, and Edward W Frykman
The most active insider trader at Arrowhead Pharmaceuticals Inc is Christopher Richard Anzalone with 29 trades.
Christopher Richard Anzalone has sold the most Arrowhead Pharmaceuticals Inc stock with a total value of $63,003,719.17.
Christopher Richard Anzalone has bought the most Arrowhead Pharmaceuticals Inc stock with a total value of $202,240.00.
The most recent insider trade for Arrowhead Pharmaceuticals Inc was on Dec. 18, 2024.
The single biggest insider buy for Arrowhead Pharmaceuticals Inc was from Christopher Richard Anzalone with a total value of $101,120.00 on Oct. 15, 2014.
The single biggest insider sell for Arrowhead Pharmaceuticals Inc was from Patrick O'brien with a total value of $7,961,400.00 on Feb. 8, 2021.